Marinomed Biotech AG
MARI.VI · VIE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €27 | €44 | €85 | €130 |
| - Cash | €2 | €3 | €8 | €6 |
| + Debt | €30 | €22 | €23 | €16 |
| Enterprise Value | €54 | €64 | €99 | €140 |
| Revenue | €5 | €9 | €11 | €12 |
| % Growth | -48.3% | -18.6% | -3% | – |
| Gross Profit | -€4 | €1 | €2 | €1 |
| % Margin | -89.9% | 12.4% | 19% | 12.2% |
| EBITDA | -€7 | -€4 | -€3 | -€4 |
| % Margin | -151.3% | -39.4% | -28.5% | -30.8% |
| Net Income | -€15 | -€7 | -€6 | -€6 |
| % Margin | -324.8% | -74% | -56.7% | -50.7% |
| EPS Diluted | -8.67 | -4.5 | -4.27 | -3.99 |
| % Growth | -92.7% | -5.4% | -7% | – |
| Operating Cash Flow | – | -€5 | -€5 | -€5 |
| Capital Expenditures | – | -€0 | -€0 | -€1 |
| Free Cash Flow | – | -€5 | -€5 | -€6 |